TRX1 flag C32S Citations (3)

Originally described in: Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner.
Liu Y, Min W Circ Res. 2002 Jun 28. 90(12):1259-66. PubMed Journal

---

Articles Citing TRX1 flag C32S

Articles
Cerium Oxide Nanoparticles Sensitize Pancreatic Cancer to Radiation Therapy through Oxidative Activation of the JNK Apoptotic Pathway. Wason MS, Lu H, Yu L, Lahiri SK, Mukherjee D, Shen C, Das S, Seal S, Zhao J. Cancers (Basel). 2018 Sep 1;10(9). pii: cancers10090303. doi: 10.3390/cancers10090303. PubMed
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Zhang J, Prasad C, Oo A, Qiu Z, Li N, Singh D, Xin X, Cho YJ, Li Z, Zhang X, Yan C, Zheng Q, Shao J, Wang QE, Kim B. Res Sq. 2023 May 2:rs.3.rs-2814118. doi: 10.21203/rs.3.rs-2814118/v1. Preprint. PubMed
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Prasad CB, Oo A, Liu Y, Qiu Z, Zhong Y, Li N, Singh D, Xin X, Cho YJ, Li Z, Zhang X, Yan C, Zheng Q, Wang QE, Guo D, Kim B, Zhang J. Nat Commun. 2024 May 31;15(1):4667. doi: 10.1038/s41467-024-48076-9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.